Clinical Trials in France / NCT07388992
Recruiting
Observational
Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
NCT07388992 · tracked via the Priya Life Science France tracker
Condition(s) studied
Multiple SclerosisHealthy Adult
Study summary
The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)
Eligibility
Inclusion Criteria:
For people living with multiple sclerosis (pwMS):
1. Age at inclusion between =18 and =65 years old
2. Signed informed consent and ability to comply with study and follow-up.
3. Confirmed MS diagnosis according to McDonald criteria (2017)
4. Expanded Disability Status Scale EDSS = 6
5. Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies)
6. Ability and willingness to participate in and comply with all study procedures defined in the protocol
7. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
For Healthy volunteers :
1. Age at inclusion between =18 and =65 years old
2. Signed informed consent and ability to comply with study and follow-up.
3. Ability and willingness to participate in and comply with all study procedures defined in the protocol
4. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
Exclusion Criteria:
For pwMS:
1. Participants with a relapse within the past 3 months before the inclusion
2. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
3. Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
4. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
For healthy volunteers (HV):
1. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
2. Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
3. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
Primary outcome measure(s)
- description of ambulation pattern in controlled environment in people living with multiple sclerosis (pwMS) with different disease severities — enrollment
Measurement of daily life-like activity movements by Optical Motion Capture, pressure sensitive walkway and wearable sensors
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Lille | Lille | France | Recruiting |
More SYSNAV trials in France
Other trials for the same condition
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Active, not recruiting
Screening for Cognitive Disorders in Multiple Sclerosis
Starting soon
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Active, not recruiting
LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07388992 on ClinicalTrials.gov ↗ ← All trials in France